Literature DB >> 17409326

Viral hepatitis in HIV infection.

Margaret James Koziel1, Marion G Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17409326      PMCID： PMC4144044          DOI： 10.1056/NEJMra065142

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  95 in total

1.  Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.

Authors:  Gennadiy Koev; Tatyana Dekhtyar; Lixin Han; Ping Yan; Teresa I Ng; C Thomas Lin; Hongmei Mo; Akhteruzzaman Molla
Journal:  Antiviral Res       Date:  2006-08-17       Impact factor: 5.970

2.  Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Authors:  Fabrice Carrat; Firouzé Bani-Sadr; Stanislas Pol; Eric Rosenthal; Françoise Lunel-Fabiani; Asmae Benzekri; Patrice Morand; Cécile Goujard; Gilles Pialoux; Lionel Piroth; Dominique Salmon-Céron; Claude Degott; Patrice Cacoub; Christian Perronne
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

3.  Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.

Authors:  J J Goedert; A Hatzakis; K E Sherman; M E Eyster
Journal:  J Infect Dis       Date:  2001-09-13       Impact factor: 5.226

Review 4.  Liver transplantation in HIV-infected recipients.

Authors:  Michelle E Roland; Peter G Stock
Journal:  Semin Liver Dis       Date:  2006-08       Impact factor: 6.115

5.  Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Authors:  Patrick S Sullivan; Debra L Hanson; Eyasu H Teshale; Linda L Wotring; John T Brooks
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

Review 6.  Assessment of liver fibrosis in co-infected patients.

Authors:  T Barry Kelleher; Nezam Afdhal
Journal:  J Hepatol       Date:  2005-11-28       Impact factor: 25.083

7.  Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.

Authors:  K Pogány; H L Zaaijer; J M Prins; F W Wit; J M A Lange; M G H M Beld
Journal:  AIDS Res Hum Retroviruses       Date:  2005-11       Impact factor: 2.205

8.  Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

Authors:  M F Yuen; E Sablon; C K Hui; H J Yuan; H Decraemer; C L Lai
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 9.  Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.

Authors:  J J Goedert; D L Brown; K Hoots; K E Sherman
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

10.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391
View more
  103 in total

1.  Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.

Authors:  Aaron P Thrift; Jennifer R Kramer; Christine M Hartman; Kathryn Royse; Peter Richardson; Yongquan Dong; Suchismita Raychaudhury; Roxanne Desiderio; Dina Sanchez; Sharmila Anandasabapathy; Donna L White; Elizabeth Y Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

2.  HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Authors:  Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara
Journal:  Antivir Ther       Date:  2016-05-11

Review 3.  Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Authors:  Neliswa A Gogela; Ming V Lin; Jessica L Wisocky; Raymond T Chung
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

4.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients.

Authors:  Ma Teresa Pérez-Rodríguez; Bernardo Sopeña; Manuel Crespo; Alberto Rivera; Teresa González del Blanco; Antonio Ocampo; César Martínez-Vázquez
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

5.  Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.

Authors:  Sandra Olukemi Ogwu-Richard; David Ajiboye Ojo; Olusola Abiodun Akingbade; Iheanyi Omezuruike Okonko
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

Review 6.  Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.

Authors:  O El-Sherif; D Back
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

7.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

Review 8.  Hepatitis C treatment: current and future perspectives.

Authors:  Saira Munir; Sana Saleem; Muhammad Idrees; Aaliyah Tariq; Sadia Butt; Bisma Rauff; Abrar Hussain; Sadaf Badar; Mahrukh Naudhani; Zareen Fatima; Muhmmad Ali; Liaqat Ali; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Zunaira Awan
Journal:  Virol J       Date:  2010-11-01       Impact factor: 4.099

Review 9.  Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation.

Authors:  Stephen E Congly; Karen E Doucette; Carla S Coffin
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.

Authors:  Jennifer Gillis; Curtis Cooper; Sean Rourke; Sergio Rueda; Kelly O'Brien; Evan Collins; Anita Rachlis; Trevor A Hart; Janet Raboud
Journal:  Qual Life Res       Date:  2012-10-17       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.